Biosimilars Will Lift Sandoz Following Q2 Sales Slump

Reversal Of COVID-19 Impact Hurts Top Line

 
• By Dean Rudge
Weight_Lifting
Sandoz is eyeing a lift from biosimilars in H2 • Source: Shutterstock

More from Biosimilars

More from Products